NDC51457-0210-01: ISOSORBIDE MONONITRATE EXTENDED-.
ISOSORBIDE MONONITRATE EXTENDED-. Key specifications include administration: ORAL, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, PLASTIC, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 120.000 MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ISOSORBIDE MONONITRATE 120MG TABS CARDIOVASCULAR 100S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-509-4427, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | EXTENDED RELEASE FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY ARTERY DISEASE. STORE AT 25 C (77 F); USP CONTROLLED ROOM TEMPERATURE |
| long_action_method | EXTENDED RELEASE |
| primary_container_type | BOTTLE, PLASTIC |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 120.000 MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ISOSORBIDE MONONITRATE 120MG TABS CARDIOVASCULAR 100S |
| american_hospital_formulary_service_classification_number | 241208 |
| NSN | 6505-01-509-4427 |
| LONG ACTION METHOD | EXTENDED RELEASE |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE, PLASTIC |
| SPECIAL FEATURES | EXTENDED RELEASE FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY ARTERY DISEASE. STORE AT 25 C (77 F); USP CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ISOSORBIDE MONONITRATE 120MG TABS CARDIOVASCULAR 100S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 241208 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 120.000 MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT |